IP Library Granted Patent US 11,383,059
Granted Patent B2
US 11,383,059 · App. 17/459,058 · Granted Jul 12, 2022

Conversion of nitrogen dioxide (NO

Inventors: David P. Rounbehler (Lexington, MA); David H. Fine (Cocoa Beach, FL)
Assignee: VERO Biotech Inc.
A61M16/12A61D7/04A61M16/0057A61M16/10A61M16/104C01B21/24A61M15/00A61M2016/102A61M2202/0275
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,383,059
App. No.
17/459,058
Granted
Jul 12, 2022
Kind
B2
Abstract

Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.

Claims (48)

1. A method, comprising:

conveying a nitrogen dioxide-containing gas from a tankless gas source that contains dinitrogen tetroxide to a cartridge; and

passing the nitrogen dioxide-containing gas through the cartridge to remove the nitrogen dioxide, producing a nitric oxide-containing gas.

2. The method of claim 1 , wherein the cartridge includes a reducing agent configured to react with nitrogen dioxide to produce nitric oxide.

3. The method of claim 1 , wherein the cartridge includes a substrate coated with a reducing agent, the method further comprises:

flowing the nitrogen dioxide-containing gas over the substrate such that the reducing agent converts nitrogen dioxide in the nitrogen dioxide-containing gas to nitric oxide.

4. The method of claim 2 , further comprising delivering the nitric oxide-containing gas to a patient.

5. The method of claim 3 , further comprising delivering the nitric oxide-containing gas to a patient.

6. The method of claim 1 , further comprising delivering the nitric oxide-containing gas to a patient.

7. A method, comprising:

conveying a nitrogen dioxide-containing gas to a cartridge; and

passing the nitrogen dioxide-containing gas through the cartridge, the cartridge including at least one of vitamin C or vitamin E configured to react with nitrogen dioxide to remove the nitrogen dioxide and produce a nitric oxide-containing gas.

8. The method of claim 7 , further comprising delivering the nitric oxide-containing gas to a patient.

9. A method, comprising:

conveying a nitrogen dioxide-containing gas to a cartridge; and

passing the nitrogen dioxide-containing gas through the cartridge, the cartridge including silica gel wetted with ascorbic acid such that the nitrogen dioxide-containing gas flows over the silica gel and such that the ascorbic acid reacts with nitrogen dioxide to produce a nitric oxide-containing gas.

10. The method of claim 9 , wherein:

the silica gel is porous and has a mesh size between 35 and 70.

11. The method of claim 9 , further comprising delivering the nitric oxide-containing gas to a patient.

12. The method of claim 10 , further comprising delivering the nitric oxide-containing gas to a patient.

13. A method, comprising:

conveying a nitrogen dioxide-containing gas to a cartridge;

passing the nitrogen dioxide-containing gas through the cartridge to remove the nitrogen dioxide, producing a nitric oxide-containing gas;

mixing the nitric oxide-containing gas with an oxygen-containing gas; and

delivering the nitric oxide-containing gas to a patient after mixing the nitric oxide-containing gas and the oxygen-containing gas.

14. The method of claim 13 , wherein the nitric oxide-containing gas is supplied to a ventilator prior to being delivered to the patient.

15. The method of claim 13 , further comprising delivering the nitric oxide-containing gas to a flexible bag prior to delivering the nitric-oxide containing gas to the patient such that a constant supply of nitric oxide can be delivered to the patient during inhalation.

16. The method of claim 13 , wherein the nitric oxide is delivered to the patient to treat pulmonary hypertension.

17. The method of claim 13 , wherein the patient is a newborn and the nitric oxide is delivered to treat persistent pulmonary hypertension.

18. The method of claim 13 , wherein the nitric oxide is delivered to the patient to treat bronchopulmonary dysplasia.

19. The method of claim 13 , wherein the patient is a cardiac surgery patient.

20. A method, comprising:

conveying a nitrogen dioxide-containing gas from an unpressurized tankless gas source to a cartridge; and

passing the nitrogen dioxide-containing gas through the cartridge to remove the nitrogen dioxide, producing a nitric oxide-containing gas.

21. The method of claim 20 , further comprising delivering the nitric oxide-containing gas to a patient.

22. A method, comprising:

conveying a nitrogen dioxide-containing gas to a cartridge;

passing the nitrogen dioxide-containing gas through the cartridge to remove the nitrogen dioxide, producing a nitric oxide-containing gas;

measuring a concentration of nitrogen dioxide in the nitric oxide-containing gas before the nitric oxide-containing gas is delivered to a patient; and

generating an alarm when a concentration of nitrogen dioxide in the nitric-oxide containing gas exceeds a threshold.

23. A method, comprising:

conveying a nitrogen dioxide-containing gas to a cartridge; and

passing the nitrogen dioxide-containing gas through the cartridge, the cartridge including a nontoxic reducing agent configured to react with nitrogen dioxide to produce a nitric oxide-containing gas.

24. The method of claim 23 , further comprising delivering the nitric oxide-containing gas to a patient.

25. A method, comprising:

conveying a nitrogen dioxide-containing gas to a cartridge; and

passing the nitrogen dioxide-containing gas through the cartridge, the cartridge including a reducing agent configured to react with nitrogen dioxide to produce nitric oxide, removing all nitrogen dioxide from nitrogen dioxide-containing gas and producing a nitric oxide-containing gas.

26. The method of claim 25 , further comprising delivering the nitric oxide-containing gas to a patient.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2021
From: ROUNBEHLER, DAVID P.; FINE, DAVID H.
To: CYTERRA CORPORATION
Reel/Frame 057360/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2021
From: CYTERRA CORPORATION
To: GENO LLC
Reel/Frame 057360/0096 →
CHANGE OF NAME Recorded Sep 1, 2021
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 057393/0960 →
Continuity (10)
Continuation 17080306 · Oct 26, 2020
Continuation 16186790 · Nov 12, 2018
Continuation 15385354 · Dec 20, 2016
Continuation 14107629 · Dec 16, 2013
Continuation 13555567 · Jul 23, 2012
Continuation 13298970 · Nov 17, 2011
Continuation 12500929 · Jul 10, 2009
Continuation 11206305 · Aug 18, 2005
Provisional Application 60602333 · Aug 18, 2004
Related Publication 20210393915A1 · Dec 23, 2021